Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1966 2
1967 1
1978 1
1982 2
1984 1
1988 1
1989 1
1990 5
1991 1
1993 2
1994 4
1995 2
1996 3
1997 4
1999 3
2000 3
2001 9
2002 12
2003 10
2004 6
2005 11
2006 18
2007 15
2008 18
2009 19
2010 13
2011 22
2012 15
2013 12
2014 14
2015 14
2016 12
2017 15
2018 8
2019 8
2020 6
2021 8
2022 7
2023 10
2024 12
2025 15
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.
Takahashi M, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Kawasaki Y, Kato T, Tatarano S, Masui K, Nakamura E, Kaneko T, Miyake M, Kitano G, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. Takahashi M, et al. Among authors: kurahashi t. Clin Genitourin Cancer. 2025 Jun;23(3):102322. doi: 10.1016/j.clgc.2025.102322. Epub 2025 Feb 26. Clin Genitourin Cancer. 2025. PMID: 40118720
Solitary Cardiac Metastasis of Hepatocellular Carcinoma.
Kurahashi T, Hosui A, Hiramatsu N. Kurahashi T, et al. Intern Med. 2025 May 15;64(10):1610-1611. doi: 10.2169/internalmedicine.4470-24. Epub 2024 Oct 25. Intern Med. 2025. PMID: 39462591 Free PMC article. No abstract available.
Black Esophagus in Hyperosmolar Hyperglycemic Syndrome.
Kurahashi T, Yamada T, Hosui A, Hiramatsu N. Kurahashi T, et al. Intern Med. 2025 Jun 15;64(12):1941-1942. doi: 10.2169/internalmedicine.4663-24. Epub 2024 Nov 21. Intern Med. 2025. PMID: 39566978 Free PMC article. No abstract available.
Parathyroid carcinoma detected within the thyroid.
Otake K, Kondo Y, Tsukamoto K, Kurahashi T, Sato K, Ozawa H, Yokoi K, Watanabe M. Otake K, et al. Among authors: kurahashi t. Nagoya J Med Sci. 2021 May;83(2):367-374. doi: 10.18999/nagjms.83.2.367. Nagoya J Med Sci. 2021. PMID: 34239185 Free PMC article.
Physiological and pathological views of peroxiredoxin 4.
Fujii J, Ikeda Y, Kurahashi T, Homma T. Fujii J, et al. Among authors: kurahashi t. Free Radic Biol Med. 2015 Jun;83:373-9. doi: 10.1016/j.freeradbiomed.2015.01.025. Epub 2015 Feb 2. Free Radic Biol Med. 2015. PMID: 25656995 Review.
Dehydrogenative Diels-Alder reaction.
Ozawa T, Kurahashi T, Matsubara S. Ozawa T, et al. Among authors: kurahashi t. Org Lett. 2011 Oct 7;13(19):5390-3. doi: 10.1021/ol202283d. Epub 2011 Sep 9. Org Lett. 2011. PMID: 21905638
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T. Mori K, et al. Among authors: kurahashi t. Cancer Sci. 2025 Feb;116(2):444-452. doi: 10.1111/cas.16326. Epub 2024 Nov 17. Cancer Sci. 2025. PMID: 39550694 Free PMC article.
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N. Kikuchi H, et al. Among authors: kurahashi t. Jpn J Clin Oncol. 2025 Apr 26;55(5):531-538. doi: 10.1093/jjco/hyaf018. Jpn J Clin Oncol. 2025. PMID: 39893579
315 results